Back
Neurogene, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
NGNE
Neurogene, Inc.
Last Price:
$21.12
Seasonality Move:
21.41%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiNeurogene, Inc. Stock Forecast
-
Over the next 52 weeks, Neurogene, Inc. has on average historically risen by 21.6% based on the past 11 years of stock performance.
-
Neurogene, Inc. has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Neurogene, Inc. Stock Undervalued?The current Neurogene, Inc. [NGNE] share price is $20.76. The Score for NGNE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Neurogene, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Neurogene, Inc. has on average historically risen by 21.6% based on the past 11 years of stock performance.
Neurogene, Inc. Stock Rating
Sell
41
Neurogene, Inc. (NGNE)
is a Sell
Is Neurogene, Inc. overpriced?
-
Neurogene, Inc. has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Neurogene, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
37.27
52-Week Low:
6.88
Prediction Charts
Market Cap:
321.6M
Price in USD:
20.76
Volume:
147K
Beta:
-1.15
Technical Analysis
SMA50:
26.17
SMA100:
22.97
SMA200:
19.76
52-Wk Change:
-12.41%
Stock Predictions
-
Is Neurogene, Inc. stock public?Yes, Neurogene, Inc. is a publicly traded company.
-
What is the Neurogene, Inc. stock quote today?The Neurogene, Inc. stock price is 20.76 USD today.
-
How to buy Neurogene, Inc. stock online?You can buy Neurogene, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-20 | 21.56 | 20.40 | 22.42 | 19.68 |
| Nov-21 | 20.28 | 20.06 | 21.26 | 19.77 |
| Nov-24 | 20.32 | 20.44 | 21.03 | 19.88 |
| Nov-25 | 20.65 | 20.74 | 21.11 | 20.12 |
| Nov-26 | 20.78 | 20.99 | 21.73 | 19.91 |
| Nov-28 | 21.12 | 21.08 | 21.79 | 20.77 |
| Dec-1 | 20.82 | 20.48 | 21.11 | 19.67 |
| Dec-2 | 20.53 | 19.24 | 20.62 | 19.23 |
| Dec-3 | 19.49 | 20.12 | 20.31 | 19.26 |
| Dec-4 | 20.06 | 21.16 | 23.00 | 19.88 |
| Dec-5 | 21.18 | 20.28 | 22.06 | 20.19 |
| Dec-8 | 20.86 | 20.59 | 21.87 | 20.46 |
| Dec-9 | 20.65 | 19.74 | 21.13 | 19.65 |
| Dec-10 | 19.81 | 20.76 | 21.11 | 19.66 |
Neurogene, Inc. Earnings
Neurogene, Inc. Earnings Report: Per Share Neurogene, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene, Inc. Forecast Revenue Growth
Neurogene, Inc. Stock Analysis: Historical quarterly revenues per share for Neurogene, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.71 per share.
* Neurogene, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.